Find therapies in clinical trials near you – page 37

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

Study on the Effects of Atacicept in Adults with IgA Nephropathy

Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Study Comparing Bleeding Risk of Rivaroxaban and Apixaban in Patients with Acute Venous Thromboembolism

Study Comparing Bleeding Risk of Rivaroxaban and Apixaban in Patients with Acute Venous Thromboembolism

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Study on the Effects of Modified-Release Hydrocortisone vs. Immediate-Release Hydrocortisone for Patients with Addison's Disease

Study on the Effects of Modified-Release Hydrocortisone vs. Immediate-Release Hydrocortisone for Patients with Addison's Disease

Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma